Trial results
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to the results reported on ClinicalTrials.gov, this trial looked at a brain stimulation technique called repetitive Transcranial Magnetic Stimulation (rTMS) — a procedure that uses magnetic pulses directed at the head — as a potential treatment for auditory hallucinations (hearing voices or sounds that aren't there). A total of 50 people took part: 27 were assigned to receive active rTMS and 23 received a sham (dummy/placebo) version that mimicked the procedure without the active stimulation. Of those, 25 in the active group and 21 in the placebo group completed the trial. The reported data shows that the main thing being measured was a "Hallucination Change Score" (HCS), rated on a scale where 0 means hallucinations stopped, 10 means no change, and 20 means they became twice as severe. After nine sessions, the active rTMS group reported an average score of 5.85, while the placebo group reported an average of 8.61. For a secondary measure looking at how often hallucinations occurred (on a 0–9 scale where higher means more frequent), the active group showed an average change of 1.42 points from their starting point, compared to 0.15 for the placebo group. On a separate "Clinical Global Improvement" scale (where 1 is dramatically improved and 7 is dramatically worsened), the active group averaged 2.84 and the placebo group averaged 3.79. The reported data also shows that 14 out of 27 participants in the active rTMS group were classified as "responders" (meaning their HCS score reached 5 or below), compared to 4 out of 23 in the placebo group. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.
View full results on ClinicalTrials.gov ↗ · Read the linked publication on PubMed (PMID 15936729) ↗
These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
Phase 2 Schizophrenia Trial, Completed
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- You have been diagnosed with schizophrenia or schizoaffective disorder, confirmed through a structured clinical interview.
- You hear voices (spoken speech) at least 5 times per day and can make out what the voices are saying.
- You are right-handed.
- You have been on the same antipsychotic medication(s) for at least 4 weeks without any changes.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- You have a history of seizures (unless they were caused by drug withdrawal or a medication you no longer take).
- A parent, sibling, or child of yours has been diagnosed with epilepsy.
- Your estimated IQ is below 80.
- You are not able to give informed consent to participate in the study.
- You have a serious medical condition that is not currently stable.
- You are currently being treated with clozapine or bupropion.
- You have cochlear implants or any other metal in your head from surgery or any other source.
- You have a history of irregular heart rhythm (cardiac arrhythmia).
- You have a cardiac pacemaker.
- You have been actively using drugs or alcohol in the past 6 weeks.
- You are pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial was run
These are the locations recorded on the registry, and they are a historical record: this trial is not enrolling, so they are not places you can join it.
Primary endpoints
Hallucination Change Score (HCS) After 9 Active/Sham rTMS Sessions
Other options
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.